Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

Background Primary sclerosing cholangitis (PSC) is relatively rare disease and
pathogenesis and methods of treatments were still not established. Then, we had conducted …

Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary
disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of …

These guidelines on the management of primary sclerosing cholangitis (PSC) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are infrequent
autoimmune cholestatic liver diseases, that disproportionate to their incidence and …

IgG4‐related sclerosing cholangitis (IgG4‐SC) is a distinct type of cholangitis frequently
associated with autoimmune pancreatitis and currently recognized as a biliary manifestation …

PSC is a heterogeneous disease with a variety of clinical outcomes, both fatal and nonfatal.
The progression of liver fibrosis in an individual patient is difficult to predict and may vary …

Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease. Sub-types of
PSC have been described, most recently PSC with elevated serum and/or tissue IgG4 …

Introduction Primary sclerosing cholangitis (PSC) is a progressive cholestatic disorder that
ultimately can lead to cirrhosis, liver failure, malignancy and death. It is strongly associated …

Background Several studies have demonstrated that elevated serum IgG4 levels are
associated with poor outcomes of primary sclerosing cholangitis (PSC), but the impact of …